论文信息 - Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.

Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.

A series of aryltetrazolylacetanilides was synthesized and evaluated as HIV-1 non-nucleoside reverse transcriptase inhibitors on wild-type virus and on the clinically relevant K103N mutant strain. Extensive SAR investigation led to potent compounds, with nanomolar activity on K103N, and orally bioavailable in rats.

[1] A. D. Clark,et al. The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance. , 2001, Journal of molecular biology.

[2] L. Bacheler,et al. Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[3] P. Darke,et al. L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4] JD Lundgren,et al. Changing patterns of mortality across Europe in patients infected with HIV-1 , 1998, The Lancet.

[5] Erik De Clercq. Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection , 1999 .

[6] O. Pirola,et al. Synthesis of 4-keto-1H,4,5-dihydro-1,2,5-benzotriazepines and their chemical behaviour☆ , 1968 .